Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance

by Maicol Mancini, Quentin-Dominique Thomas, Sylvia Bourdel, Laura Papon, Emilie Bousquet, Prisca Jalta, Silvia La Monica, Camille Travert, Roberta Alfieri, Xavier Quantin, Marta Cañamero, Antonio Maraver
Published 2021-07-01

Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib

by Silvia La Monica, Claudia Fumarola, Daniele Cretella, Mara Bonelli, Roberta Minari, Andrea Cavazzoni, Graziana Digiacomo, Maricla Galetti, Francesco Volta, Maicol Mancini, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri
Published 2021-12-01

MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis

by Diala Kantar, Emilie Bousquet Mur, Maicol Mancini, Vera Slaninova, Yezza Ben Salah, Luca Costa, Elodie Forest, Patrice Lassus, Charles Géminard, Florence Boissière-Michot, Béatrice Orsetti, Charles Theillet, Jacques Colinge, Christine Benistant, Antonio Maraver, Lisa Heron-Milhavet, Alexandre Djiane
Published 2021-03-01

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors

by Maicol Mancini, Hilah Gal, Nadège Gaborit, Luigi Mazzeo, Donatella Romaniello, Tomer Meir Salame, Moshit Lindzen, Georg Mahlknecht, Yehoshua Enuka, Dominick GA Burton, Lee Roth, Ashish Noronha, Ilaria Marrocco, Dan Adreka, Raya Eilam Altstadter, Emilie Bousquet, Julian Downward, Antonio Maraver, Valery Krizhanovsky, Yosef Yarden
Published 2018-02-01